Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8955872 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 11 Pages |
Abstract
These results could provide a rationale for dose de-escalation studies in brachytherapy for patients displaying optimal GTV volumetric reduction after chemoradiotherapy and may reinforce the need for dose escalation in poorly responding patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Antoine MD, MSc, Sophie MD, Pierre MD, MSc, Ingrid MD, MSc, Alexandre MD, MSc, Fabien MD, MSc, Manon MD, Philippe MD, PhD, Enrica MD, Sebastien MD, Eric MD, PhD, Christine MD, Cyrus MD, PhD,